{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:46:08Z","timestamp":1794084368650,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871002"],"award-info":[{"award-number":["81871002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Foundation of Chongqing,China","award":["CSTB2024NSCQ-MSX0757"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0757"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01100-1","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:15:03Z","timestamp":1755058503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts"],"prefix":"10.1038","volume":"11","author":[{"given":"Huimin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Parkinson\u2019s Progression Markers Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Chen-Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Dahodwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Siderowf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Mamikonyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gochanour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Caspell-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne D.","family":"Dobkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana M.","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Eberling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Espay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Leverenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene H.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Simuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele K.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47, https:\/\/doi.org\/10.1038\/s41572-021-00280-3 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1100_CR2","doi-asserted-by":"publisher","unstructured":"Puig-Davi, A. et al. Prediction of cognitive heterogeneity in Parkinson\u2019s disease: a 4-year longitudinal study using clinical, neuroimaging, biological and electrophysiological biomarkers. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.27035 (2024).","DOI":"10.1002\/ana.27035"},{"key":"1100_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"1100_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","volume":"111","author":"M Carceles-Cordon","year":"2023","unstructured":"Carceles-Cordon, M., Weintraub, D. & Chen-Plotkin, A. S. Cognitive heterogeneity in Parkinson\u2019s disease: a mechanistic view. Neuron 111, 1531\u20131546 (2023).","journal-title":"Neuron"},{"key":"1100_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee, S. H., Park, S. Y. & Choi, C. S. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab. J. 46, 15\u201337 (2022).","journal-title":"Diabetes Metab. J."},{"key":"1100_CR6","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan, H. et al. Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression. Mov. Disord. 36, 1420\u20131429 (2021).","journal-title":"Mov. Disord."},{"key":"1100_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315","author":"D Bosco","year":"2012","unstructured":"Bosco, D. et al. Dementia is associated with insulin resistance in patients with Parkinson\u2019s disease. J. Neurol. Sci. 315, 39\u201343 (2012).","journal-title":"J. Neurol. Sci."},{"key":"1100_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JPD-181305","volume":"8","author":"E Hogg","year":"2018","unstructured":"Hogg, E. et al. High prevalence of undiagnosed insulin resistance in non-diabetic subjects with Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 8, 259\u2013265 (2018).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1100_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell, J., Blunt, E., Gupta, D. & Edison, P. Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res. Rev. 89, 101979 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1100_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1515\/cclm-2021-0643","volume":"59","author":"B Matli","year":"2021","unstructured":"Matli, B. et al. Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals. Clin. Chem. Lab. Med. 59, 1844\u20131851 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1100_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01274-x","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc. Diabetol. 20, 82 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"1100_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jad.2024.05.049","volume":"359","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Association between triglyceride glucose index and cognitive decline: A meta-analysis. J. Affect. Disord. 359, 70\u201377 (2024).","journal-title":"J. Affect. Disord."},{"key":"1100_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.amepre.2023.07.011","volume":"65","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Association of the triglyceride-glucose index with risk of Alzheimer\u2019s disease: a prospective cohort study. Am. J. Prev. Med. 65, 1042\u20131049 (2023).","journal-title":"Am. J. Prev. Med."},{"key":"1100_CR14","volume":"15","author":"N Tian","year":"2023","unstructured":"Tian, N. et al. Triglyceride-glucose index, Alzheimer\u2019s disease plasma biomarkers, and dementia in older adults: the MIND-China study. Alzheimer\u2019s Dement.15, e12426 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1100_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jagp.2023.09.007","volume":"32","author":"N Tian","year":"2024","unstructured":"Tian, N. et al. Association of triglyceride-glucose index with cognitive function and brain atrophy: a population-based study. Am. J. Geriatr. Psychiatry 32, 151\u2013162 (2024).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1100_CR16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27135","volume":"32","author":"S Fengler","year":"2017","unstructured":"Fengler, S. et al. Cognitive changes in prodromal Parkinson\u2019s disease: a review. Mov. Disord. 32, 1655\u20131666 (2017).","journal-title":"Mov. Disord."},{"key":"1100_CR17","doi-asserted-by":"publisher","unstructured":"Jellinger, K. A. Pathobiology of cognitive impairment in Parkinson disease: challenges and outlooks. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25010498 (2023).","DOI":"10.3390\/ijms25010498"},{"key":"1100_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1872214810999160628105549","volume":"10","author":"MR Ashraghi","year":"2016","unstructured":"Ashraghi, M. R., Pagano, G., Polychronis, S., Niccolini, F. & Politis, M. Parkinson\u2019s disease, diabetes and cognitive impairment. Recent Pat. Endocr. Metab. Immune Drug Discov. 10, 11\u201321 (2016).","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"1100_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda, L. E., Rodr\u00edguez-Mor\u00e1n, M. & Guerrero-Romero, F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 6, 299\u2013304 (2008).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"1100_CR20","doi-asserted-by":"publisher","unstructured":"The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635, https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005 (2011).","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"key":"1100_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-020-00758-4","volume":"13","author":"S Hong","year":"2021","unstructured":"Hong, S., Han, K. & Park, C. Y. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimer\u2019s Res. Ther. 13, 9 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"1100_CR22","doi-asserted-by":"publisher","first-page":"e068718","DOI":"10.1136\/bmj-2021-068718","volume":"379","author":"D Weintraub","year":"2022","unstructured":"Weintraub, D. et al. Management of psychiatric and cognitive complications in Parkinson\u2019s disease. BMJ 379, e068718 (2022).","journal-title":"BMJ"},{"key":"1100_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","volume":"51","author":"SJ Chung","year":"2018","unstructured":"Chung, S. J. et al. Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease. Park. Relat. Disord. 51, 43\u201348 (2018).","journal-title":"Park. Relat. Disord."},{"key":"1100_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2020.00047","volume":"11","author":"S Sasikumar","year":"2020","unstructured":"Sasikumar, S. & Strafella, A. P. Imaging mild cognitive impairment and dementia in Parkinson\u2019s disease. Front. Neurol. 11, 47 (2020).","journal-title":"Front. Neurol."},{"key":"1100_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.28124","volume":"35","author":"I P\u00e9rez-Taboada","year":"2020","unstructured":"P\u00e9rez-Taboada, I. et al. Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov. Disord. 35, 1636\u20131648 (2020).","journal-title":"Mov. Disord."},{"key":"1100_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mds.29298","volume":"38","author":"PW Cullinane","year":"2023","unstructured":"Cullinane, P. W. et al. Type 2 diabetes and Parkinson\u2019s disease: a focused review of current concepts. Mov. Disord. 38, 162\u2013177 (2023).","journal-title":"Mov. Disord."},{"key":"1100_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02218-8","volume":"18","author":"OF Elabi","year":"2021","unstructured":"Elabi, O. F., Cunha, J., Gaceb, A., Fex, M. & Paul, G. High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease. J. Neuroinflammation 18, 175 (2021).","journal-title":"J. Neuroinflammation"},{"key":"1100_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/brain\/awab015","volume":"144","author":"SH Jeong","year":"2021","unstructured":"Jeong, S. H. et al. Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson\u2019s disease. Brain 144, 1127\u20131137 (2021).","journal-title":"Brain"},{"key":"1100_CR29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/jnnp-2018-320157","volume":"90","author":"J Pasquini","year":"2019","unstructured":"Pasquini, J. et al. Clinical implications of early caudate dysfunction in Parkinson\u2019s disease. J. Neurol., Neurosurg. Psychiatry 90, 1098\u20131104 (2019).","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"1100_CR30","doi-asserted-by":"publisher","unstructured":"Ribari\u010d, S. The contribution of type 2 diabetes to Parkinson\u2019s disease aetiology. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25084358 (2024).","DOI":"10.3390\/ijms25084358"},{"key":"1100_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/oby.23761","volume":"31","author":"AB Kim","year":"2023","unstructured":"Kim, A. B. & Arvanitakis, Z. Insulin resistance, cognition, and Alzheimer disease. Obesity 31, 1486\u20131498 (2023).","journal-title":"Obesity"},{"key":"1100_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168\u2013181 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1100_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D. & Craft, S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 19, 758\u2013766 (2020).","journal-title":"Lancet Neurol."},{"key":"1100_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00288-z","volume":"11","author":"YQ Lv","year":"2022","unstructured":"Lv, Y. Q. et al. Long-term hyperglycemia aggravates \u03b1-synuclein aggregation and dopaminergic neuronal loss in a Parkinson\u2019s disease mouse model. Transl. Neurodegener. 11, 14 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1100_CR35","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4239\/wjd.v15.i7.1430","volume":"15","author":"MMI Abdalla","year":"2024","unstructured":"Abdalla, M. M. I. Insulin resistance as the molecular link between diabetes and Alzheimer\u2019s disease. World J. Diabetes 15, 1430\u20131447 (2024).","journal-title":"World J. Diabetes"},{"key":"1100_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67052-3","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z., Chen, X. & Sheng, Z. Association of triglyceride glucose-body mass index with Alzheimer\u2019s disease pathology, cognition and brain structure in non-demented people. Sci. Rep. 14, 16097 (2024).","journal-title":"Sci. Rep."},{"key":"1100_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/13872877241284216","volume":"102","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. The association of the triglyceride-glucose index with Alzheimer\u2019s disease and its potential mechanisms. J. Alzheimer\u2019s Dis.102, 77\u201388 (2024).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1100_CR38","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/mds.27806","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer, B. et al. Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease. Mov. Disord. 34, 1354\u20131364 (2019).","journal-title":"Mov. Disord."},{"key":"1100_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"1100_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.adp3645","volume":"387","author":"KM Wu","year":"2025","unstructured":"Wu, K. M. et al. Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease. Science 387, 892\u2013900 (2025).","journal-title":"Science"},{"key":"1100_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/nan.12728","volume":"47","author":"E de Pablo-Fern\u00e1ndez","year":"2021","unstructured":"de Pablo-Fern\u00e1ndez, E. et al. Faster disease progression in Parkinson\u2019s disease with type 2 diabetes is not associated with increased \u03b1-synuclein, tau, amyloid-\u03b2 or vascular pathology. Neuropathol. Appl. Neurobiol. 47, 1080\u20131091 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1100_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","volume":"28","author":"J Nowell","year":"2023","unstructured":"Nowell, J., Blunt, E. & Edison, P. Incretin and insulin signaling as novel therapeutic targets for Alzheimer\u2019s and Parkinson\u2019s disease. Mol. Psychiatry 28, 217\u2013229 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1100_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-160119","volume":"53","author":"H Li","year":"2016","unstructured":"Li, H., Jia, J. & Yang, Z. Mini-mental state examination in elderly Chinese: a population-based normative study. J. Alzheimer\u2019s Dis. 53, 487\u2013496 (2016).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1100_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05027-w","volume":"23","author":"W Zhou","year":"2023","unstructured":"Zhou, W. et al. Positive association between weight-adjusted-waist index and dementia in the Chinese population with hypertension: a cross-sectional study. BMC Psychiatry 23, 519 (2023).","journal-title":"BMC Psychiatry"},{"key":"1100_CR45","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"1100_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01100-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:30:43Z","timestamp":1757453443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01100-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01100-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}